Jennison Associates’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-18,066
| Closed | -$351K | – | 736 |
|
|
2018
Q1 | $351K | Buy |
+18,066
| New | +$351K | ﹤0.01% | 622 |
|
|
2017
Q4 | – | Sell |
-17,731
| Closed | -$360K | – | 710 |
|
|
2017
Q3 | $360K | Buy |
+17,731
| New | +$360K | ﹤0.01% | 628 |
|
|
2015
Q2 | – | Sell |
-673,653
| Closed | -$31.6M | – | 777 |
|
|
2015
Q1 | $31.6M | Sell |
673,653
-655,277
| -49% | -$30.7M | 0.03% | 396 |
|
|
2014
Q4 | $42.1M | Buy |
1,328,930
+7,650
| +0.6% | +$242K | 0.04% | 354 |
|
|
2014
Q3 | $31.3M | Sell |
1,321,280
-400,135
| -23% | -$9.49M | 0.03% | 394 |
|
|
2014
Q2 | $51.6M | Buy |
1,721,415
+309,005
| +22% | +$9.27M | 0.05% | 321 |
|
|
2014
Q1 | $37.3M | Buy |
1,412,410
+317,083
| +29% | +$8.38M | 0.04% | 370 |
|
|
2013
Q4 | $27.5M | Buy |
1,095,327
+427,839
| +64% | +$10.8M | 0.03% | 411 |
|
|
2013
Q3 | $13.7M | Sell |
667,488
-192,497
| -22% | -$3.95M | 0.01% | 459 |
|
|
2013
Q2 | $17.2M | Buy |
+859,985
| New | +$17.2M | 0.02% | 439 |
|